Federico Grossi - 06 Jan 2025 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Medical Officer
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Federico Grossi
Issuer symbol
UBX
Transactions as of
06 Jan 2025
Net transactions value
$0
Form type
4
Filing time
07 Jan 2025, 16:35:03 UTC
Previous filing
07 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 06 Jan 2025 Common Stock 150,000 $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares vest and become exercisable pursuant to the following schedule: 1/48th of the shares subject to the option vest in successive, equal monthly installments on each monthly anniversary of the Vesting Commencement Date of January 1, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.